Dr. Finance SA
1.49
PLN
+0.01
(+0.34%)
Dr. Finance SA
GPW:DRF
(Warsaw Stock Exchange)
Recent
price
1.49
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Dr. Finance SA is a Poland-based financial services company operating primarily in the financial intermediation, credit brokerage, and insurance distribution sectors. Founded in 2008 and headquartered in Wroclaw, Poland, the company provides independent financial advisory and intermediary solutions designed to connect individual retail consumers, affluent clients, and small-to-medium enterprises with commercial banks, non-bank lenders, and insurance underwriters across Poland. The company is listed on the NewConnect market of the Warsaw Stock Exchange under the ticker DRF. The company's core product and service portfolio encompasses retail and commercial lending brokerage, including residential mortgage loans, home equity loans, personal cash loans, debt consolidation loans, motor vehicle financing, working capital facilities, and commercial mortgages; insurance brokerage and distribution, including term and whole life insurance, endowment policies, homeowner and commercial property insurance, third-party liability insurance, comprehensive motor insurance, and private health coverage; and auxiliary financial planning services, including personal balance sheet consulting, investment fund distribution, pension planning advisory, and creditworthiness assessment. Dr. Finance SA delivers its solutions through partner agent networks and digital consultation channels, generating revenue primarily through success-based distribution fees and commissions from partner financial institutions. In recent operational developments, Dr. Finance SA has executed structural corporate reorganizations and strategic realignments. Following its corporate name change from Doradcy24 SA to Dr. Finance SA, the company restructured its brick-and-mortar distribution network and phased out legacy operational segments to reduce fixed overhead costs. The management board launched a comprehensive review of strategic options to evaluate long-term alternatives for the enterprise, including potential mergers and acquisitions, the onboarding of strategic financial or industry investors, asset divestitures, and prospective pivots into alternative business sectors. Across recent fiscal periods, the company has focused on corporate governance restructuring, balance sheet optimization, and the assessment of new commercial and capital opportunities to enhance shareholder value.